Skip to main content
An official website of the United States government

Cancer Survivorship Research Unit (CSRU)

As the population of cancer survivors continues to expand rapidly, there is increasing need to bring rigorous epidemiological approaches to survivorship research. DCEG responded by creating the Cancer Survivorship Research Unit (CSRU), with the goal of improving the clinical care and quality of life of cancer survivors by increasing understanding of the adverse effects of treatment through trans-disciplinary epidemiological and genetics studies. 

Division-Wide Expertise

The CSRU includes investigators from across the division with an aim of increasing trans-divisional survivorship research studies, but is housed in the Radiation Epidemiology Branch, building on the branch’s long-standing expertise in studying subsequent malignancy risks and late effects of cancer treatment.

CSRU activities are complemented by monthly seminars coordinated by the DCEG Cancer Survivorship Working Group, co-chaired by Drs. Shahinaz Gadalla, Lindsay MortonSara Schonfeld, and Jacqueline Vo.

Research Studies

Current studies led by CSRU members include a broad range of cancer survivor populations (e.g., pediatric cancer, breast cancer, hematologic malignancies), consider special populations (e.g., individuals with inherited cancer predisposition syndromes, hematopoietic stem cell transplant recipients), and assess a range of outcomes.

Survivor Populations by Cancer Type

Breast Cancer

Pediatric Cancers

Special Populations

Methods and Outcomes

For more information, contact Lindsay Morton, Ph.D.

Radiation Epidemiology Branch - Research Areas

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Cancer Survivorship Research Unit (CSRU) was originally published by the National Cancer Institute.”